Bayesian enrichment strategies for randomized discontinuation trials
DOI10.1111/J.1541-0420.2011.01623.XzbMATH Open1241.62169OpenAlexW2070311219WikidataQ36886980 ScholiaQ36886980MaRDI QIDQ2894009FDOQ2894009
Authors: Lorenzo Trippa, Gary L. Rosner, P. Müller 
Publication date: 27 June 2012
Published in: Biometrics (Search for Journal in Brave)
Full work available at URL: http://europepmc.org/articles/pmc3667626
Recommendations
- Randomized discontinuation trials with binary outcomes
- Bayesian randomized clinical trials: A decision-theoretic sequential design
- A Bayesian Approach to the Design of Phase II Clinical Trials
- Decision-Theoretic Designs for Pre-Phase II Screening Trials in Oncology
- A signature enrichment design with Bayesian adaptive randomization
Applications of statistics to biology and medical sciences; meta analysis (62P10) Medical applications (general) (92C50) Bayesian problems; characterization of Bayes procedures (62C10)
Cites Work
- Optimal Statistical Decisions
- Statistical Methods for Eliciting Probability Distributions
- Parameter Estimation in a Gompertzian Stochastic Model for Tumor Growth
- A new stochastic Gompertz diffusion process with threshold parameter: computational aspects and applications
- Optimal Design via Curve Fitting of Monte Carlo Experiments
- Stochastic Dominance among Log-Normal Prospects
- Bayes estimation of reliability for the two-parameter lognormal distribution
Cited In (6)
- Randomized discontinuation trials with binary outcomes
- Optimizing parameters in clinical trials with a randomized start or withdrawal design
- Bayesian designs and the control of frequentist characteristics: a practical solution
- Estimation of Progression-Free Survival for All Treated Patients in the Randomized Discontinuation Trial Design
- Random norming AIDS analysis of non-linear regression models with sequential informative dose selection
- Robust meta‐analytic‐predictive priors in clinical trials with historical control information
This page was built for publication: Bayesian enrichment strategies for randomized discontinuation trials
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q2894009)
